Fig. 1From: Integrating network pharmacology and experimental verification to explore the pharmacological mechanisms of asparagus against polycystic ovary syndromeSchematic representation of the proposed mechanism in ASP against PCOS. Network pharmacology was applied to analyze the crucial components and key targets of ASP for the treatment of PCOS. Molecular docking revealed that 7 components had strong binding ability to the hub gene PRKCA. Cellular assays confirmed that ASP could alleviate the course of PCOS by inhibiting the caspase cascade pathway in GCsBack to article page